Skip to main content
Atrás
CNTA logo

Centessa Pharmaceuticals plc

Calidad de datos: 100%
CNTA
NASDAQ Healthcare Biotechnology
$25.94
▼ $1.12 (-4.14%)
Cap. Mercado: 3.49B
Rango del Día
$25.82 $27.83
Rango de 52 Semanas
$9.60 $30.58
Volumen
1,533,123
Promedio 50D / 200D
$25.21 / $21.69
Cierre Anterior
$27.06

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E -14.8 0.4
P/B 8.7 2.9
ROE % -73.9 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.3 0.2

Puntos Clave

Debt/Equity of 0.29 — conservative balance sheet
Negative free cash flow of -142.09M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-73.93%
ROIC-29.07%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
0.29
Current Ratio9.25
Interest Coverage-19.93

Valoración

P/E Ratio
-14.79
P/B Ratio8.68
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -235.76M
ROE -73.93% ROA -40.87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -142.09M
ROIC -29.07% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.29 Current Ratio 9.25
Interest Coverage -19.93 Dividend Yield 0.00%
Valuation
P/E Ratio -14.79 P/B Ratio 8.68
P/S Ratio N/A PEG Ratio -0.26
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 3.49B Enterprise Value 3.22B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 6.85M 0.0 0.0 0.0
Net Income -235.76M -151.09M -216.21M -381.90M -10.66M
EPS (Diluted) -2.06 -1.57 -2.31 -4.24 -0.08
Gross Profit 0.0 6.85M 0.0 0.0 0.0
Operating Income -201.06M -171.28M -212.26M -374.87M -10.44M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 576.80M 360.25M 444.31M 629.64M 11.72M
Total Liabilities 175.25M 124.00M 108.14M 138.08M 8.62M
Shareholders' Equity 401.55M 236.24M 336.17M 491.55M 3.10M
Total Debt 117.23M 84.59M 69.80M 75.70M 5.63M
Cash & Equivalents 383.22M 128.03M 393.64M 595.08M 7.23M
Current Assets 536.41M 315.09M 437.75M 628.77M 11.17M
Current Liabilities 58.00M 39.39M 38.34M 24.64M 8.62M